Image

Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)

Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)

Recruiting
18-90 years
All
Phase N/A

Powered by AI

Overview

The Urology Unit of AOUI Verona proposes a clinical study aimed at a preliminary evaluation of postoperative complications specifically focused on robotic partial nephrectomy (RAPN) procedures using two currently available platforms:

  • DaVinci®;
  • Hugo®.

The questions it aims to answer are:

Does the estimation of the post-operative complications suggest something? Are differences (intra- and post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable?

Participants will be invited to join one of these two experimental group:

  1. surgery with the DaVinci platform;
  2. surgery with the Hugo platform.

Eligibility

Inclusion Criteria:

  • patient aged between 18 and 90 years old;
  • patient with localized kidney tumor suitable for partial nephrectomy;
  • patient able to understand and sign the informed consent;
  • patient compliance with the follow-up program.

Exclusion Criteria:

  • patient who do not fall within the inclusion age range;
  • patient not suitable for partial nephrectomy;
  • patient unable to understand and sign the informed consent;
  • patient unable to follow the monitoring program;
  • patient refusal to participate to the study.

Study details
    Renal Carcinoma

NCT06290427

Azienda Ospedaliera Universitaria Integrata Verona

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.